Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$41.72
+0.07%
Mkt Cap $2.53B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (10 analysts)
$65.00
Range $65.00 – $65.00
Implied Upside
+55.8%
Consensus $65.00 vs current $41.72